Together, this depicts that CD4+ T cell function is maintained during COVID-19 which may benefit the infected patient toward recovery, while impaired CD8+ T cell population could have a plausible contribution toward disease progression and severity (Supplementary File 1, Figure 2G). The gene discussed is CD4; the disease is COVID-19.